Sandra Ventin, Area Vice President, Benefits, Gallagher
The Rise of GLP-1 Medications in Canada: A Key Trend to Watch in 2025 To help our clients, we closely monitor prescription drug trends. One of the most significant shifts in recent years has been the rise of GLP-1 medications in Canada. We have seen a substantial increase in utilization, aligning with broader market trends. […]
Sandra Ventin, Area Vice President, Benefits, Gallagher Read More »









